Description
LY2090314 is an inhibitor of glycogen synthase kinase (GSK-3).
Product Unit Size | Cost | Quantity | Stock |
---|
LY2090314 is an inhibitor of glycogen synthase kinase (GSK-3).
Cas No. | 603288-22-8 |
---|---|
Purity | ≥98% |
Formula | C28H25FN6O3 |
Formula Wt. | 512.53 |
IUPAC Name | 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione |
Synonym | LY2090314 |
Solubility | DMSO 100 mg/mL (195.11 mM) Ethanol 2 mg/mL warmed (3.9 mM) Water Insoluble |
Appearance | Yellow Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Zamek-Gliszczynski MJ, Abraham TL, Alberts JJ, et al. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure. Drug Metab Dispos. 2013 Apr;41(4):714-26. PMID: 23305709.
AurKA/B inhibitor.
Peptide, derivative of AT II, involved in vasoc...
Benzothiazepine; L-type Ca2+ channel blocker, p...
Nitroimidazole, binds DNA; nucleic acid synthes...
Nicotinic acid derivative; InhA inhibitor.
Endogenous quaternary ammonium, required for fa...
Synthetic analog of 1,4-naphthoquinone, precurs...
γ-Secretase inhibitor.
Non-fluorescent halogenated A23187 analog, Ca2+...
Mycotoxin produced by Alternaria; photosynthesi...
p53 activator.
Endogenous peptide hormone fragment, involved i...
Benzimidazole; microtubule polymerization inhib...
Morpholine derivative.
Peptide; GABA potentiator, NMDA negative allost...
Trichothecene mycotoxin produced by Fusarium.
NS3/4A inhibitor
Endogenous pteridine metabolite of GTP.
Flavonoid found in various plant sources; DAT a...
Fermentation impurity